{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:51:35Z","timestamp":1789429895176,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.vaccine.2023.11.062","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T07:40:24Z","timestamp":1702021224000},"page":"332-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Protective effects of a novel chimeric virus\u2013like particle vaccine against virulent NDV and IBDV challenge"],"prefix":"10.1016","volume":"42","author":[{"given":"Jindou","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kainan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xibing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4833-6553","authenticated-orcid":false,"given":"Zhuang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.11.062_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.619829","article-title":"Newcastle disease virus inhibits the proliferation of T cells induced by dendritic cells in vitro and in vivo","volume":"11","author":"Nan","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2023.11.062_b0010","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.3390\/v14102253","article-title":"The over-40-years-epidemic of infectious bursal disease virus in China","volume":"14","author":"Zhang","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.11.062_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.871549","article-title":"Blood B cell depletion reflects immunosuppression induced by live-attenuated infectious bursal disease vaccines","volume":"9","author":"Courtillon","year":"2022","journal-title":"Front Vet Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.062_b0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.14202\/vetworld.2021.70-77","article-title":"Comparison of two attenuated infectious bursal disease vaccine strains focused on safety and antibody response in commercial broilers","volume":"14","author":"Thomrongsuwannakij","year":"2021","journal-title":"Vet World"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.062_b0025","first-page":"793","article-title":"Evaluation de l'innocuit\u00e9 de vaccins a virus vivants att\u00e9nu\u00e9s contre la bursite infectieuse (maladie de Gumboro) chez le poussin de chair conventionnel","volume":"27","author":"Boudaoud","year":"2008","journal-title":"Rev Sci Tech"},{"issue":"23","key":"10.1016\/j.vaccine.2023.11.062_b0030","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1016\/j.vaccine.2010.03.021","article-title":"Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein","volume":"28","author":"Zhou","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.11.062_b0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.vetmic.2016.08.016","article-title":"Chicken IL-7 as a potent adjuvant enhances IBDV VP2 DNA vaccine immunogenicity and protective efficacy","volume":"193","author":"Huo","year":"2016","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.062_b0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2016.11.029","article-title":"Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDV","volume":"35","author":"Richetta","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.062_b0045","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3390\/v11050476","article-title":"Co-expression of chicken IL-2 and IL-7 enhances the immunogenicity and protective efficacy of a VP2-expressing DNA vaccine against IBDV in chickens","volume":"11","author":"Huo","year":"2019","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.vaccine.2023.11.062_b0050","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.vaccine.2015.01.006","article-title":"Protective efficacy of a DNA vaccine construct encoding the VP2 gene of infectious bursal disease and a truncated HSP70 of Mycobacterium tuberculosis in chickens","volume":"33","author":"Maity","year":"2015","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2023.11.062_b0055","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1128\/JVI.01931-09","article-title":"Assembly and biological and immunological properties of Newcastle disease virus-like particles","volume":"84","author":"McGinnes","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.11.062_b0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.vetmic.2017.03.002","article-title":"Newcastle disease virus-like particles induce DC maturation through TLR4\/NF-\u03baB pathway and facilitate DC migration by CCR7-CCL19\/CCL21 axis","volume":"203","author":"Qian","year":"2017","journal-title":"Vet Microbiol"},{"issue":"13","key":"10.1016\/j.vaccine.2023.11.062_b0065","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.1128\/JVI.00384-15","article-title":"Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein","volume":"89","author":"McGinnes","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.11.062_b0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.vetmic.2018.12.007","article-title":"Newcastle disease virus-like particles containing the Brucella BCSP31 protein induce dendritic cell activation and protect mice against virulent Brucella challenge","volume":"229","author":"Xu","year":"2019","journal-title":"Vet Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.062_b0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12250-020-00199-1","article-title":"Chimeric newcastle disease virus-like particles containing DC-binding peptide-fused haemagglutinin protect chickens from virulent newcastle disease virus and H9N2 avian influenza virus challenge","volume":"35","author":"Xu","year":"2020","journal-title":"Virol Sin"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.062_b0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/v11030254","article-title":"Construction and immunogenicity of novel chimeric virus-like particles bearing antigens of infectious bronchitis virus and newcastle disease virus","volume":"11","author":"Wu","year":"2019","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.vaccine.2023.11.062_b0085","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00705-008-0115-9","article-title":"Genomic analysis of Newcastle disease virus strain NA-1 isolated from geese in China","volume":"153","author":"Xu","year":"2008","journal-title":"Arch Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.062_b0090","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.vaccine.2018.11.068","article-title":"A genotype VII Newcastle disease virus-like particles confer full protection with reduced virus load and decreased virus shedding","volume":"37","author":"Xu","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.11.062_b0095","first-page":"555","article-title":"Newcastle disease. Manual of diagnostic tests and vaccines for terrestrial animals: mammals, birds and bees","author":"Oie","year":"2012","journal-title":"Biological Standards Commission World Organisation for Animal Health"},{"issue":"46","key":"10.1016\/j.vaccine.2023.11.062_b0100","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1016\/j.vaccine.2007.09.006","article-title":"Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens","volume":"25","author":"Rong","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.062_b0105","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/21645515.2015.1011993","article-title":"Protection conferred by virus-like particle vaccines against respiratory syncytial virus infection in mice by intranasal vaccination","volume":"11","author":"Gu","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.11.062_b0110","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12967-015-0705-8","article-title":"Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein","volume":"13","author":"Cullen","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.vaccine.2023.11.062_b0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.gene.2019.05.008","article-title":"Improved translation efficiency of therapeutic mRNA","volume":"707","author":"Zarghampoor","year":"2019","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.062_b0120","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00438-019-01534-2","article-title":"Optimization of a 2A self-cleaving peptide-based multigene expression system for efficient expression of upstream and downstream genes in silkworm","volume":"294","author":"Wang","year":"2019","journal-title":"Mol Genet Genomics"},{"key":"10.1016\/j.vaccine.2023.11.062_b0125","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3389\/fimmu.2020.01100","article-title":"Interaction between virus-like particles (VLPs) and pattern recognition receptors (PRRs) from dendritic cells (DCs): toward better engineering of VLPs","volume":"11","author":"Zepeda-Cervantes","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.062_b0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/vaccines6030037","article-title":"Interaction of viral capsid-derived virus-like particles (VLPs) with the innate immune system","volume":"6","author":"Mohsen","year":"2018","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"10.1016\/j.vaccine.2023.11.062_b0135","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4155\/tde.14.74","article-title":"Antigen delivery by virus-like particles for immunotherapeutic vaccination","volume":"5","author":"Al-Barwani","year":"2014","journal-title":"Ther Deliv"},{"issue":"11","key":"10.1016\/j.vaccine.2023.11.062_b0140","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.4049\/jimmunol.153.11.4925","article-title":"Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules","volume":"153","author":"Harding","year":"1994","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2023.11.062_b0145","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1073\/pnas.90.11.4942","article-title":"Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages","volume":"90","author":"Kovacsovics-Bankowski","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2023.11.062_b0150","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1007\/s00253-021-11615-1","article-title":"Solutions against emerging infectious and noninfectious human diseases through the application of baculovirus technologies","volume":"105","author":"Targovnik","year":"2021","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.062_b0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cellimm.2009.12.005","article-title":"Baculovirus activates murine dendritic cells and induces non-specific NK cell and T cell immune responses","volume":"262","author":"Suzuki","year":"2010","journal-title":"Cell Immunol"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2023.11.062_b0160","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0264-410X(00)00259-0","article-title":"Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles","volume":"19","author":"Rueda","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.11.062_b0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.fsi.2022.06.008","article-title":"An inactivated vaccine against infectious pancreatic necrosis virus in rainbow trout (Oncorhynchus mykiss)","volume":"127","author":"Duan","year":"2022","journal-title":"Fish Shellfish Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.062_b0170","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41598-017-08247-9","article-title":"Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23014305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23014305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T14:57:58Z","timestamp":1715180278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23014305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0264410X23014305"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of a novel chimeric virus\u2013like particle vaccine against virulent NDV and IBDV challenge","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}